Bristol-Myers Squibb (BMY) Tops Q2 EPS by 14c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
Bristol-Myers Squibb Reports Second Quarter Financial Results
July 26, 2018 6:59 AM EDTIncreases Second Quarter Revenues 11% to $5.7 Billion Posts Second Quarter GAAP EPS of $0.23 and Non-GAAP EPS of $1.01 Achieves Significant Regulatory Milestones in Oncology Presents Important New Data on Immuno-Oncology Portfolio at ASCO Updates 2018 GAAP and Non-GAAP EPS Guidance
NEW YORK--(BUSINESS WIRE)--... More

